Bernhard Dorweiler - Concepedia

Author

Bernhard Dorweiler

Johannes Gutenberg University Mainz ORCID

Also Known As

B Dorweiler, B. Dorweiler, B. Dorweiler, Bernhard DORWEILER, Bernhard Dorweiler, Grischa Hoffmann, Michael Torzewski, S Boor

186

Publications

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Columbia University University of Applied Sciences Mainz Universitäts-Herzzentrum Freiburg-Bad Krozingen

About

Bernhard Dorweiler is an author at Johannes Gutenberg University Mainz specializing in medicine, surgery, and vascular surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	1.7K
2	Engineering	4	4	134
3	Natural Sciences	2	2	210
4	Biochemistry	2	2	210
5	Public Health	1	1	14

Bernhard Dorweiler

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques Gabrielle Fredman, Jason Hellmann, Jonathan D. Proto, Nature Communications	2016	389
Adaptive suppression of the ATF4–CHOP branch of the unfolded protein response by toll-like receptor signalling Connie W. Woo, Dongying Cui, Jerry Arellano, Nature Cell Biology Atf4–chop BranchToll-like ReceptorsSignal TransductionSignaling PathwayInnate Immune System	2009	270
MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis Bishuang Cai, Edward B. Thorp, Amanda C. Doran, Journal of Clinical Investigation Vascular DiseaseImmunologyMertk Receptor CleavagePathologyCell Death	2017	237
Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism Yankun Li, Yuan Zhang, Bernhard Dorweiler, Journal of Biological Chemistry	2008	206
On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. S Bhakdi, Bernhard Dorweiler, R. Kirchmann, The Journal of Experimental Medicine Cholesterol EsteraseOxidative StressMetabolic SyndromeLdl ParticlesCardiovascular Disease Pathogenesis	1995	195
Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion Michael Torzewski, Mariam Klouche, Johann Hock, Arteriosclerosis Thrombosis and Vascular Biology	1998	182
Ischemia-Reperfusion Injury Bernhard Dorweiler, Diethard Pruefer, Terézia B. Andrási, European Journal of Trauma and Emergency Surgery	2007	155
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial Tilman Reiff, Hans‐Henning Eckstein, Ulrich Mansmann, The Lancet Neurology Carotid EndarterectomyCarotid Artery SurgeryCardiovascular DiseaseEndovascular TechniqueVascular Surgery	2022	128
CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis Amanda C. Doran, Lale Özcan, Bishuang Cai, Journal of Clinical Investigation Vascular DiseaseThicker Collagen CapsImmunologyImmune RegulationPathology	2017	106
Atherogenic Properties of Enzymatically Degraded LDL Mariam Klouche, Sandra Gottschling, Verena B. Gerl, Arteriosclerosis Thrombosis and Vascular Biology	1998	83

Page 1